Nuclear factor (NF)-κB controls expression of the immunoregulatory glycan-binding protein galectin-1

Molecular Immunology

Volumn 48, Issue 15-16, 2011, Pages 1940-1949

  Toscano, Marta A ^a,b   Campagna, Leonardo ^b,e   Molinero, Luciana L ^b,f   Cerliani, Juan P ^a   Croci, Diego O ^a,b   Ilarregui, Juan M ^a,b   Fuertes, Mercedes B ^a,b   Nojek, Ignacio M ^c   Fededa, Juan P ^d,g   Zwirner, Norberto W ^a,b,d   Costas, Mónica A ^c   Rabinovich, Gabriel A ^a,b,d  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^c INSTITUTO DE INVESTIGACIONES MÉDICAS ALFREDO LANARI   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e MUSEO ARGENTINO DE CIENCIAS NATURALES BERNARDINO RIVADAVIA   (Argentina)

^f UNIVERSITY OF CHICAGO   (United States)

^g ETH ZURICH   (Switzerland)

Author keywords

Galectin 1; Inflammation; NF B; T cells

Indexed keywords

GALECTIN 1; GLYCAN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; SYNAPTOTAGMIN I; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOME 22; CONTROLLED STUDY; CYTOPLASM; DNA BINDING; DOWN REGULATION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; INHIBITION KINETICS; INTRON; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; WESTERN BLOTTING;

BINDING SITES; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEEDBACK, PHYSIOLOGICAL; GALECTIN 1; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMANS; MICROSCOPY, CONFOCAL; NF-KAPPA B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSFECTION;

EID: 80051923641     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2011.05.021     Document Type: Article

References (48)

1. Barrionuevo P., Beigier-Bompadre M., Ilarregui J.M., Toscano M.A., Bianco G.A., Isturiz M.A., Rabinovich G.A. A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J. Immunol. 2007, 178:436-445.
2. Blaser C., Kaufmann M., Muller C., Zimmermann C., Wells V., Mallucci L., Pircher H. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur. J. Immunol. 1998, 28:2311-2319.
3. Blois S.M., Ilarregui J.M., Tometten M., Garcia M., Orsal A.S., Cordo-Russo R., Toscano M.A., Bianco G.A., Kobelt P., Handjiski B., Tirado I., Markert U.R., Klapp B.F., Poirier F., Szekeres-Bartho J., Rabinovich G.A., Arck P.C. A pivotal role for galectin-1 in fetomaternal tolerance. Nat. Med. 2007, 13:1450-1457.
4. Cartharius K., Frech K., Grote K., Klocke B., Haltmeier M., Klingenhoff A., Frisch M., Bayerlein M., Werner T. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 2005, 21:2933-2942.
5. Coornaert B., Carpentier I., Beyaert R. A20: central gatekeeper in inflammation and immunity. J. Biol. Chem. 2009, 284:8217-8221.
6. Costas M., Trapp T., Pereda M.P., Sauer J., Rupprecht R., Nahmod V.E., Reul J.M., Holsboer F., Arzt E. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids. TNF-alpha priming increases glucocorticoid inhibition of TNF-alpha-induced cytotoxicity/apoptosis. J. Clin. Invest. 1996, 98:1409-1416.
7. Fuertes M.B., Molinero L.L., Toscano M.A., Ilarregui J.M., Rubinstein N., Fainboim L., Zwirner N.W., Rabinovich G.A. Regulated expression of galectin-1 during T-cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase. Mol. Cell. Biochem. 2004, 267:177-185.
8. Garin M.I., Chu C.C., Golshayan D., Cernuda-Morollon E., Wait R., Lechler R.I. Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. Blood 2007, 109:2058-2065.
9. Gauthier S., Pelletier I., Ouellet M., Vargas A., Tremblay M.J., Sato S., Barbeau B. Induction of galectin-1 expression by HTLV-I Tax and its impact on HTLV-I infectivity. Retrovirology 2008, 5:105-119.
10. Ghosh S., Hayden M.S. New regulators of NF-kappaB in inflammation. Nat. Rev. Immunol. 2008, 8:837-848.
11. Green D.R., Droin N., Pinkoski M. Activation-induced cell death in T cells. Immunol. Rev. 2003, 193:70-81.
12. Hsu D.K., Hammes S.R., Kuwabara I., Greene W.C., Liu F.T. Human T lymphotropic virus-I infection of human T lymphocytes induces expression of the beta-galactoside-binding lectin, galectin-3. Am. J. Pathol. 1996, 148:1661-1670.
13. Ilarregui J.M., Croci D.O., Bianco G.A., Toscano M.A., Salatino M., Vermeulen M.E., Geffner J.R., Rabinovich G.A. Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10. Nat. Immunol. 2009, 10:981-991.
14. Imhof A., Wolffe A.P. Transcription: gene control by targeted histone acetylation. Curr. Biol. 1998, 8:R422-R424.
15. Juszczynski P., Ouyang J., Monti S., Rodig S.J., Takeyama K., Abramson J., Chen W., Kutok J.L., Rabinovich G.A., Shipp M.A. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:13134-13139.
16. Kavurma M.M., Khachigian L.M. Signaling and transcriptional control of Fas ligand gene expression. Cell Death Differ. 2003, 10:36-44.
17. Koh H.S., Lee C., Lee K.S., Ham C.S., Seong R.H., Kim S.S., Jeon S.H. CD7 expression and galectin-1-induced apoptosis of immature thymocytes are directly regulated by NF-kappaB upon T-cell activation. Biochem. Biophys. Res. Commun. 2008, 370:149-153.
18. Laderach D.J., Compagno D., Toscano M.A., Croci D.O., Dergan-Dylon S., Salatino M., Rabinovich G.A. Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings. IUBMB Life 2010, 62:1-13.
19. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb. Perspect. Biol. 2009, 1:a001651.
20. Li Z.W., Rickert R.C., Karin M. Genetic dissection of antigen receptor induced-NF-kappaB activation. Mol. Immunol. 2004, 41:701-714.
21. Lin B., Williams-Skipp C., Tao Y., Schleicher M.S., Cano L.L., Duke R.C., Scheinman R.I. NF-kappaB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Differ. 1999, 6:570-582.
22. Liu F.T., Rabinovich G.A. Galectins: regulators of acute and chronic inflammation. Ann. NY Acad. Sci. 2010, 1183:158-182.
23. Liu L., Sakai T., Sano N., Fukui K. Nucling mediates apoptosis by inhibiting expression of galectin-3 through interference with nuclear factor kappaB signaling. Biochem. J. 2004, 380:31-41.
24. Motran C.C., Molinder K.M., Liu S.D., Poirier F., Miceli M.C. Galectin-1 functions as a Th2 cytokine that selectively induces Th1 apoptosis and promotes Th2 function. Eur. J. Immunol. 2008, 38:3015-3027.
25. Nieminen J., Kuno A., Hirabayashi J., Sato S. Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J. Biol. Chem. 2007, 282:1374-1383.
26. Norling L.V., Sampaio A.L., Cooper D., Perretti M. Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking. FASEB J. 2008, 22:682-690.
27. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases. Nat. Rev. Immunol. 2009, 9:778-788.
28. Perillo N.L., Pace K.E., Seilhamer J.J., Baum L.G. Apoptosis of T cells mediated by galectin-1. Nature 1995, 378:736-739.
29. Perone M.J., Bertera S., Tawadrous Z.S., Shufesky W.J., Piganelli J.D., Baum L.G., Trucco M., Morelli A.E. Dendritic cells expressing transgenic galectin-1 delay onset of autoimmune diabetes in mice. J. Immunol. 2006, 177:5278-5289.
30. Rabinovich G., Castagna L., Landa C., Riera C.M., Sotomayor C. Regulated expression of a 16-kd galectin-like protein in activated rat macrophages. J. Leukoc. Biol. 1996, 59:363-370.
31. Rabinovich G.A., Daly G., Dreja H., Tailor H., Riera C.M., Hirabayashi J., Chernajovsky Y. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J. Exp. Med. 1999, 190:385-398.
32. Rabinovich G.A., Iglesias M.M., Modesti N.M., Castagna L.F., Wolfenstein-Todel C., Riera C.M., Sotomayor C.E. Activated rat macrophages produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J. Immunol. 1998, 160:4831-4840.
33. Rabinovich G.A., Ramhorst R.E., Rubinstein N., Corigliano A., Daroqui M.C., Kier-Joffe E.B., Fainboim L. Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms. Cell Death Differ. 2002, 9:661-670.
34. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352.
35. Renner F., Schmitz M.L. Autoregulatory feedback loops terminating the NF-kappaB response. Trends Biochem. Sci. 2009, 34:128-135.
36. Rubinstein N., Alvarez M., Zwirner N.W., Toscano M.A., Ilarregui J.M., Bravo A., Mordoh J., Fainboim L., Podhajcer O.L., Rabinovich G.A. Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. Cancer Cell 2004, 5:241-251.
37. Santucci L., Fiorucci S., Rubinstein N., Mencarelli A., Palazzetti B., Federici B., Rabinovich G.A., Morelli A. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 2003, 124:1381-1394.
38. Satelli A., Rao U.S. Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells. Cancer Lett. 2011, 301:38-46.
39. Stillman B.N., Hsu D.K., Pang M., Brewer C.F., Johnson P., Liu F.T., Baum L.G. Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death. J. Immunol. 2006, 176:778-789.
40. Stowell S.R., Qian Y., Karmakar S., Koyama N.S., Dias-Baruffi M., Leffler H., McEver R.P., Cummings R.D. Differential roles of galectin-1 and galectin-3 in regulating leukocyte viability and cytokine secretion. J. Immunol. 2008, 180:3091-3102.
41. Toscano M.A., Bianco G.A., Ilarregui J.M., Croci D.O., Correale J., Hernandez J.D., Zwirner N.W., Poirier F., Riley E.M., Baum L.G., Rabinovich G.A. Differential glycosylation of TH1, TH2 and TH-17 effector cells selectively regulates susceptibility to cell death. Nat. Immunol. 2007, 8:825-834.
42. Toscano M.A., Commodaro A.G., Ilarregui J.M., Bianco G.A., Liberman A., Serra H.M., Hirabayashi J., Rizzo L.V., Rabinovich G.A. Galectin-1 suppresses autoimmune retinal disease by promoting concomitant Th2- and T regulatory-mediated anti-inflammatory responses. J. Immunol. 2006, 176:6323-6332.
43. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
44. van der Leij J., van den Berg A., Harms G., Eschbach H., Vos H., Zwiers P., van Weeghel R., Groen H., Poppema S., Visser L. Strongly enhanced IL-10 production using stable galectin-1 homodimers. Mol. Immunol. 2007, 44:506-513.
45. van Kooyk Y., Rabinovich G.A. Protein-glycan interactions in the control of innate and adaptive immune responses. Nat. Immunol. 2008, 9:593-601.
46. Vereecke L., Beyaert R., van Loo G. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. Trends Immunol. 2009, 30:383-391.
47. Werbajh S., Nojek I., Lanz R., Costas M.A. RAC-3 is a NF-kappa B coactivator. FEBS Lett. 2000, 485:195-199.
48. Zuñiga E., Rabinovich G.A., Iglesias M.M., Gruppi A. Regulated expression of galectin-1 during B-cell activation and implications for T-cell apoptosis. J. Leukoc. Biol. 2001, 70:73-79.